Sex is Good Podcast
Sex is Good.
And we’re done pretending otherwise.
The Sex Is Good podcast exists to say the quiet part out loud: sex is fun, sex is normal, and sex is something adults get to enjoy without shame, fear, or bad information.
Hosted by the founder of a sex-positive telehealth company and a medical provider who actually understands how bodies work in the real world, this podcast breaks down the science of sex, STIs, desire, performance, relationships, and pleasure — without pearl-clutching, scare tactics, or outdated sex-ed nonsense.
We talk about the things you weren’t taught in school.
We unlearn the myths you were taught.
And we remind you that having a great sex life and taking care of your sexual health are not opposites — they’re partners.
Yes, we talk about STIs.
Yes, we talk about testing and prevention.
And no, that doesn’t mean sex has to be boring, stressful, or wrapped in shame.
You can absolutely have your cake and eat it too. You can have a wild, fulfilling, adventurous sex life and be informed, responsible, and confident about your health. In fact, we’d argue that’s the whole point.
This isn’t a sex story podcast.
It’s a sex science, sex truth, and sex freedom podcast.
Smart, evidence-based, irreverent, and unapologetically pro-pleasure.
Because sex is good. And we’re done pretending it’s not.
Sex is Good Podcast
GLP-1 Drugs: How They Actually Work and the Pharma Drama Behind Them
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
GLP-1 medications like Ozempic, Wegovy, and Mounjaro are some of the most talked-about drugs in the world right now. But how do they actually work, and what’s really going on behind the scenes?
In this episode, we break down the science of GLP-1 receptor agonists in plain English, including how they affect appetite, insulin, gastric emptying, and long-term weight loss. We also review clinical trial data, real-world outcomes, and what happens when people stop taking these medications.
Then we go deeper into the part most people aren’t talking about: drug shortages, compounded GLP-1 alternatives, and the rapidly growing gray market. We explain how compounding pharmacies operate during FDA-declared shortages, what “copycat” or “bootleg” versions really are, and where the legal lines start to blur.
We also discuss recent FDA actions, enforcement trends, and the broader pharmaceutical landscape, including pricing, patents, and why these drugs have become such a massive financial battleground. From stock volatility to regulatory pressure, there’s more going on here than just weight loss.
If you’ve been hearing about GLP-1 drugs everywhere and want a clear, honest explanation of both the science and the controversy, this episode gives you the full picture.